Qube Research & Technologies (QRT)’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.8K Buy
+378
New +$33.1K ﹤0.01% 3235
2025
Q2
Sell
-204
Closed -$14.4K 3731
2025
Q1
$14.4K Sell
204
-178
-47% -$12.4K ﹤0.01% 3253
2024
Q4
$25.1K Sell
382
-533
-58% -$36.7K ﹤0.01% 3165
2024
Q3
$64.6K Sell
915
-556
-38% -$38.7K ﹤0.01% 2816
2024
Q2
$97.6K Buy
1,471
+1,286
+695% +$84.3K ﹤0.01% 2610
2024
Q1
$12.6K Buy
185
+74
+67% +$4.89K ﹤0.01% 3768
2023
Q4
$6.86K Sell
111
-1,986
-95% -$117K ﹤0.01% 3667
2023
Q3
$124K Sell
2,097
-16,707
-89% -$1.02M ﹤0.01% 2584
2023
Q2
$170K Buy
18,804
+16,065
+587% +$955K ﹤0.01% 1821
2023
Q1
$160K Sell
2,739
-897
-25% -$54K ﹤0.01% 2001
2022
Q4
$226K Sell
3,636
-915
-20% -$55K ﹤0.01% 1763
2022
Q3
$257K Buy
+4,551
New +$280K ﹤0.01% 1683
2022
Q1
Sell
-198
Closed -$13K 2705
2021
Q4
$13K Buy
198
+144
+267% +$9.13K ﹤0.01% 2381
2021
Q3
$3K Sell
54
-1,146
-96% -$72.9K ﹤0.01% 2091
2021
Q2
$74K Buy
+1,200
New +$73K ﹤0.01% 1984

Other funds holding IHE

Qube Research & Technologies (QRT)'s IHE Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q1 2026: 378 shares worth $32.8K. The stake represents ﹤0.01% of the portfolio and ranks #3235 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in IHE as recently as Q1 2025.

Qube Research & Technologies (QRT) first reported a position in IHE in Q2 2021 and has held it in 15 quarters since. The position peaked at $257K in Q3 2022. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Qube Research & Technologies (QRT) held 378 shares of iShares US Pharmaceuticals ETF worth $32.8K as of Q1 2026.
  • iShares US Pharmaceuticals ETF was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3235 holding.
  • Qube Research & Technologies (QRT) first reported a position in iShares US Pharmaceuticals ETF in Q2 2021 and has held it in 15 quarters since.
  • Qube Research & Technologies (QRT)'s iShares US Pharmaceuticals ETF position peaked at $257K in Q3 2022.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.